CSIR Central

Synthesis, Structure - Activity Relationships and Biological Studies of Chromenochalcones as Potential Antileishmanial Agents

IR@CDRI: CSIR-Central Drug Research Institute, Lucknow

View Archive Info
 
 
Field Value
 
Creator Shivahare, Rahul
Korthikunta, Venkateswarlu
Chandasana, Hardik
Suthar, M K
Agnihotri, Pragati
Vishwakarma, Preeti
Telaprolu, K C
Kancharla, Papireddy
Khaliq, Tanvir
Gupta, Shweta
Bhatta, R S
Pratap, J V
Saxena, J K
Gupta, Suman
Tadigoppula, Narender
 
Date 2014-05-09T09:12:53Z
2014-05-09T09:12:53Z
2014
 
Identifier J. Med. Chem. 2014, 57, 3342−3357
http://hdl.handle.net/123456789/1221
 
Description Antileishmanial activities of a library of synthetic chalcone analogues have been examined. Among them, five compounds (11, 14, 16, 17, 22 and 24) exhibited better activity than the marketed drug miltefosine in in vitro studies against intracellular amastigotes form of Leishmania donovani. Three promising compounds 16, 17 and 22 were tested in L. donovani / hamster model. Oral administration of chalcone 16, at a concentration of 100 mg/kg of body weight per day for 5 consecutive days resulted in >84% parasite inhibition at day 7 post-treatment and it retained the activity till day 28. The molecular and immunological studies revealed that compound 16 has a dual nature to act as a direct parasite killing agent and as a host immunostimulant. Pharmacokinetics and serum albumin binding studies also suggest that compound 16 has potential to be a candidate for the treatment of non-healing form of leishmaniasis.
 
Format 1044992 bytes
application/pdf
 
Language en
 
Relation CSIR-CDRI communication number 8645
 
Subject Chromenochalcones
Biological Studies
Antileishmanial
Synthesis
 
Title Synthesis, Structure - Activity Relationships and Biological Studies of Chromenochalcones as Potential Antileishmanial Agents
 
Type Article